Danaher (DHR) Stock Price & Analysis

DHR$233.02+0.86 +0.37%
Medical - Diagnostics & ResearchLarge Cap
Compare
Market cap$163.94BEnterprise value$185.95BRevenue (TTM)$25.61BMarket positionTop 25%

Score

44
Bearish
Value
32
Quality
51
Growth
50

AI Analysis

Snapshot

Danaher doesn’t screen as a clean setup today — Stocklytics 44/100 leaves more to prove. Under the hood: P/E 38.4.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

32
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

50
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

51
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Danaher Corporation (DHR) last printed $233.02. Equity value is $163.94B. Trailing earnings multiple 37.85. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$16.88B$18.33B$17.05B$17.91B$22.28B$29.45B$26.64B$23.89B$23.88B$24.57B

About

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Danaher (DHR) Stock Price & Analysis

DHR price $233.02 +0.86 +0.37%

Ticker
DHR
Price
$233.02
Change
+0.86 +0.37%
Market cap
$163.94B
P/E
37.85
Forward P/E
25.63
Dividend yield
0.65%
Beta
0.80
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Stocklytics score
44
Value
32
Quality
51
Growth
50

Stocklytics score rationale: value 32, quality 51, growth 50.

AI Score 75. Danaher Corporation has a solid market capitalization of $163.25 billion and a price of $232.23, indicating strong investor confidence. However, its price-to-earnings ratio of approximately 37.95 suggests it may be overvalued relative to its earnings, despite a healthy net profit margin of 16.91% and consistent revenue growth in recent quarters

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener